Porcilis APP reduces financial losses by reducing the costs of medication while preventing growth retardation from chronic infections.
Porcilis APP
Porcilis APP is a sub-unit vaccine based on 4 antigens covering all 13 Actinobacillus pleuropneumoniae (APP) serotypes. Serotyping before vaccination is therefore not necessary.
Vaccination with Porcilis APP protects against financial losses by significantly reducing the costs of medication against APP as well as preventing growth retardation from chronic APP infections
For more information about Porcilis APP see:
- Porcilis APP Description
- Porcilis APP product brochure:
